预测局部晚期直肠癌新辅助放化疗病理完全缓解的深度学习模型(Table 1)

基于842例局部晚期直肠癌患者的表格数据,用于深度学习模型预测新辅助放化疗后的病理完全缓解。

NIAID Data Ecosystem
浏览 18
表格rectal cancerdeep learningneoadjuvant chemoradiotherapypathological complete responseartificial intelligence
Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer

基本信息

模态
表格
大小
0.000018465 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

预测局部晚期直肠癌新辅助放化疗病理完全缓解的深度学习模型(Table 1)

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 18.46 KB,主题涵盖 rectal cancer、deep learning、neoadjuvant chemoradiotherapy、pathological complete response、artificial intelligence,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.docx》。配套论文《Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI》发表于 Radiology(2020),DOI:10.1148/radiol.2020190936。源站首次发布:2022-06-08。

【数据内容】

源站原始描述:ObjectiveThis study aimed to develop an artificial intelligence model for predicting the pathological complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) of locally advanced rectal cancer (LARC) using digital pathological images. BackgroundnCRT followed by total mesorectal excision (TME) is a standard treatment strategy for patients with LARC. Predicting the PCR to nCRT of LARC remine difficulty. Methods842 LARC patients treated with standard nCRT from three medical centers were retr…

中文译文(机器翻译,仅供快速理解,请以原文为准):目的 本研究旨在开发一种人工智能模型,利用数字病理图像预测局部晚期直肠癌(LARC)对新辅助放化疗(n

【数据结构与技术规格】

文件数 1 个,合计 18.46 KB。Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,18.46 KB。数据集 DOI:10.3389/fonc.2022.807264.s003。

【主题与分类】

源站学科分类:Cancer、Haematological Tumours、Molecular Targets、Radiation Therapy、Oncology and Carcinogenesis not elsewhere classified、Solid Tumours。主题标签:rectal cancer、deep learning、neoadjuvant chemoradiotherapy、pathological complete response、artificial intelligence。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Table_1_Deep_Learning_Model_for_Predicting_the_Pathological_Complete_Response_to_Neoadjuvant_Chemoradiotherapy_of_Locally_Advanced_Rectal_Cancer_docx/20024519

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Lou, Xiaoying; Zhou, Niyun; Feng, Lili; Li, Zhenhui; Fang, Yuqi; Fan, Xinjuan; et al. (2022). Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.docx. Frontiers. Dataset

【使用注意】

· 源站最后修改于 2023-06-01,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.docx" "https://ndownloader.figshare.com/files/35741573"

文件清单

  • Table_1_Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer.docx(18.46 KB)

文件总体积 18.46 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ObjectiveThis study aimed to develop an artificial intelligence model for predicting the pathological complete response (pCR) to neoadjuvant chemoradiotherapy (nCRT) of locally advanced rectal cancer (LARC) using digital pathological images.
BackgroundnCRT followed by total mesorectal excision (TME) is a standard treatment strategy for patients with LARC. Predicting the PCR to nCRT of LARC remine difficulty.
Methods842 LARC patients treated with standard nCRT from three medical centers were retrospectively recruited and subgrouped into the training, testing and external validation sets. Treatment response was classified as pCR and non-pCR based on the pathological diagnosis after surgery as the ground truth. The hematoxylin & eosin (H&E)-stained biopsy slides were manually annotated and used to develop a deep pathological complete response (DeepPCR) prediction model by deep learning.
ResultsThe proposed DeepPCR model achieved an AUC-ROC of 0.710 (95% CI: 0.595, 0.808) in the testing cohort. Similarly, in the external validation cohort, the DeepPCR model achieved an AUC-ROC of 0.723 (95% CI: 0.591, 0.844). The sensitivity and specificity of the DeepPCR model were 72.6% and 46.9% in the testing set and 72.5% and 62.7% in the external validation cohort, respectively. Multivariate logistic regression analysis showed that the DeepPCR model was an independent predictive factor of nCRT (P=0.008 and P=0.004 for the testing set and external validation set, respectively).
ConclusionsThe DeepPCR model showed high accuracy in predicting pCR and served as an independent predictive factor for pCR. The model can be used to assist in clinical treatment decision making before surgery.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fonc.2022.807264.s003(source: https://frontiersin.figshare.com/articles/dataset/Table_1_Deep_Learning_Model_for_Predicting_the_Pathological_Complete_Response_to_Neoadjuvant_Chemoradiotherapy_of_Locally_Advanced_Rectal_Cancer_docx/20024519)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案